Company pioneering the connected medical device revolution with the world’s smallest biological tissue sensor
Franz Bozsak, CEO and co-founder
Sensome is a clinical stage, innovative start-up developing a breakthrough sensor technology that can turn invasive medical devices into connected healthcare devices. This revolutionary sensing technology combines impedance-based micro-sensors with machine learning algorithms to instantly identify biological tissues upon contact with an unequaled predictive reliability. Its first application is the Clotild® connected guidewire for the treatment of ischemic stroke.
Ischemic stroke can now be treated by removing the clot blocking the brain blood vessel using mechanical thrombectomy devices. Without knowledge of the clot’s characteristics, the clot, currently, is only successfully removed on the first attempt in one of every three cases and clot characteristics can impact patient prognosis. Sensome’s technology aims to provide information on the clot during the intervention thanks to the integration of Sensome’s tissue sensor into a guidewire. The Clotild® Smart Guidewire is currently undergoing clinical trials.
Sensome’s sensor technology can be deployed in multiple other medical fields, such as peripheral vascular intervention and oncology. The company’s international and interdisciplinary team possesses the skills and know-how to develop high-impact connected medical devices. The team is also supported by experienced MedTech entrepreneurs, key opinion leaders in interventional neuroradiology, and pioneer scientists from prestigious universities.
The company was founded in 2014 by aerospace engineer Franz Bozsak alongside Abdul Barakat and Bruno Carreel who brought together a team of renowned scientists, engineers and doctors to realize their vision of connected medical devices. “Bringing Clotild® to patients opened the next chapter for Sensome,” emphasizes Franz Bozsak, CEO and co-founder of Sensome, “The future of interventional therapies depends on accessing the right information at the right time. We have developed the technology to empower medical devices with the required connectivity and data, be it in stroke or other medical fields.”
Bozsak, who obtained a M.S. in Aerospace Engineering from the University of Stuttgart and a Ph.D. from Ecole Polytechnique in Biomedical Engineering and is a graduate of the Stanford Ignite/Polytechnique business program, was named Innovator Under 35 by the MIT Technology Review in 2016.
